Maintaining bone health: from strength to toughness

Weibo XIA

Director of endocrinology department at Peking Union Medical College Hospital of Chinese Academy of Medical Sciences, Director of Key Laboratory of Endocrinology at National Health Commission

Board Member of the Chinese Medical Association, Fifth Chairman of Osteoporosis Bone Mineral Salt Disease Branch of Chinese Medical Association (CMA)

Chairman of Health Communication Branch of Chinese Preventive Medical Association

Vice Chairman of the Endocrinology Branch of Chinese Medical Association

Vice President of the Endocrinology Professional Committee of Chinese Medical Doctor Association

Chairman-elect of the Endocrinology Branch of Beijing Medical Association

Board Member of the Scientific Advisory Committee of the International Osteoporosis Foundation, Board Member of the Asia-Pacific Osteoporosis Alliance

Recipient of the Special Government Allowance of the State Council

夏维波

中国医学科学院北京协和医院内分泌科主任，国家卫健委内分泌重点实验室主任
中华医学会理事、骨质疏松和骨矿盐疾病分会第五届主任委员
中华预防医学会健康传播分会主任委员
中华医学会内分泌病学分会副主任委员
中国医师协会内分泌专业委员会副会长
北京医学会内分泌分会候任主任委员
国际骨质疏松基金会科学顾问委员会理事，亚太骨质疏松联盟理事
国务院特殊津贴获得者

Professor M Kassim Javaid

University of Oxford

Professor of Osteoporosis and Adult Rare Bone Diseases, University of Oxford and an honorary consultant adult rheumatologist at Oxford University Hospitals NHS Foundation Trust.

He specializes in common and rare metabolic bone diseases. He is the clinical lead for Oxford Fracture Prevention Service, and the national Fracture Liaison Service Audit for England and Wales and serves on the Board of the Fragility Fracture Network. He also is the clinical lead for the Oxford Rare bone disease service for adults and Rare Disease Collaborative Network for Adult Rare Bone Diseases. His research interests include the epidemiology of musculoskeletal diseases with a focus on rare bone disorders and secondary fracture prevention.

Kassim Javaid教授

英国牛津大学

英国牛津大学骨质疏松症和成人罕见骨疾病教授，牛津大学医院 NHS 信托基金会成人风湿病名誉顾问医生

他擅长常见和罕见的代谢性骨病。 他是牛津骨折预防服务、英格兰和威尔士全国骨折联络服务审计的临床负责人，并担任脆性骨折网络董事会成员。 他还是牛津成人罕见骨病服务和成人罕见骨病合作网络的临床负责人。 他的研究兴趣包括肌肉骨骼疾病流行病学，重点是罕见骨病和二级骨折预防。

Ian Reid is an endocrinologist and Distinguished Professor at the University of Auckland. His research interests include calcium metabolism, vitamin D, osteoporosis and Paget’s disease. He has worked extensively in the development of the bisphosphonates for use in osteoporosis and Paget’s disease, and also on the safety and efficacy of calcium supplements, vitamin D deficiency and supplementation, and has been involved in development of most new osteoporosis treatments in the last 30 years. In recent years, his work has focused on interventions that are effective in reducing fracture rate, since that is the final clinically important endpoint in preventing and managing osteoporosis. He has also had an increasing role in writing reviews of osteoporosis management.

He is a past-president of the International Bone and Mineral Society (IBMS) and the Australian & New Zealand Bone & Mineral Society (ANZBMS), and recipient of research awards from the European Calcified Tissue Society, the American Society of Bone and Mineral Research, the ANZBMS and the New Zealand Prime Minister’s Science Prize.

Ian Reid是奥克兰大学（University of Auckland）的内分泌专家和特聘教授。 他的研究兴趣包括钙代谢、维生素 D、骨质疏松症和 Paget 病。 他在开发用于治疗骨质疏松症和 Paget 病的双膦酸盐方面做了大量工作，还研究了钙补充剂、维生素 D 缺乏和补充的安全性和有效性，并参与了过去 30 年中大多数骨质疏松症新疗法的开发。 近年来，他的工作重点是有效降低骨折率的干预措施，因为骨折率是预防和控制骨质疏松症的最终临床重要终点。 他还在撰写骨质疏松症管理综述方面发挥着越来越重要的作用。

他是国际骨与矿物质学会（IBMS）和澳大利亚与新西兰骨与矿物质学会（ANZBMS）的前任主席，曾获得欧洲钙化组织学会、美国骨与矿物质研究学会、澳大利亚与新西兰骨与矿物质学会和新西兰总理科学奖的研究奖项。

Zhou Hou-De, M.D., ph.D.

Professor and doctoral supervisor of the Second Xiangya Hospital of Central South University. Deputy director of the National Clinical Medical Research Center for Metabolic Diseases. Director of the Key Laboratory of Metabolic Bone Disease of Hunan Province. Member of the Standing Committee of Diabetes Prevention and Control Committee, Chinese Society for Preventive Medicine; Deputy Chairman of Endocrinology Expert Committee, Chairman of the Osteoporosis Prevention and Control Committee of Hunan Preventive Medical Association; Leader of high-level health talents in Hunan Province.

Focused on clinical and basic research on metabolic diseases such as osteoporosis and obesity, he has conducted research on more than 20 national projects such as the National Science and Technology Support Plan, the National Natural Science Foundation, and published more than 120 academic papers.

周后德

中南大学湘雅二医院教授、博士生导师。 国家代谢性疾病临床医学研究中心副主任。 代谢性骨病湖南省重点实验室主任。 中华预防医学会糖尿病防治专业委员会常委、内分泌学专家委员会副主任委员、湖南省预防医学会骨质疏松防治专业委员会主任委员、湖南省高层次卫生人才领军人才。

专注于骨质疏松症、肥胖症等代谢性疾病的临床和基础研究，主持国家科技支撑计划、国家自然科学基金等国家级项目20余项，发表学术论文120余篇。

Jianmin Liu

Chief physician, Professor, Vice Chief. Department of Endocrine and Metabolic Diseases, Rui-jin Hospital, Shanghai Jiao-tong University School of Medicine；

Associate Chief-Editor of 《 Chinese Journal of Endocrinology and Metabolism 》, 《 Journal of Diabetes》, 《 Endocrine》 , 《Journal of Clinical Endocrinology and Metabolism》，

Mainly focusing on clinical and basic research of endocrine and metabolic diseases, especially metabolic bone disorders.

刘建民

上海交通大学医学院附属瑞金医院内分泌代谢科，主任医师，教授，博导；

《中华内分泌代谢杂志》副主编，编辑部主任;《Journal of Diabetes》、 《Endocrine》和《Journal of Clinical Endocrinology and Metabolism》副主编，

主要从事内分泌代谢病，尤其是代谢性骨病的临床和基础研究。